Génome Canada

Génome Canada

October 16, 2009 14:42 ET

Genome Canada's Founding President and CEO Steps Down After 10 Years of Service

OTTAWA, ONTARIO--(Marketwire - Oct. 16, 2009) - Dr. Martin Godbout, Genome Canada's founding President and CEO, is stepping down following ten years of exemplary service, to return to the private sector and pursue other opportunities in the genomics field.

Dr. C. Thomas Caskey, M.D., Genome Canada's Board Chair, on behalf of the Board, expressed his sincere appreciation for Dr. Godbout's contribution to Genome Canada: "Through his vision and inspiration, Martin has guided Canada's involvement in genomics and proteomics research from concept to reality. The achievements of Genome Canada scientists will have lasting scientific impact."

Over the past decade, Dr. Godbout has created a global presence through Genome Canada where Canadian scientists can participate in ground-breaking international research. With the help of a strong Genome Canada team, he secured over $840M in funding from the Government of Canada, which has resulted in the leveraging of close to $1B in leading-edge genomics and proteomics research across Canada.

"I have been honoured to work for a unique organization that represented the interests of the Canadian genomics and proteomics research community over the past 10 years." said Dr. Godbout.

The Board of Directors has appointed a Transition Team made up of a committee of the Board and management personnel. The Team will oversee the management and operations of Genome Canada activities as well as the process for the ultimate appointment of a new President and CEO.

Dr. Caskey stated "The Team was selected on the basis of their complementary expertise, knowledge of Genome Canada programs, regional leadership and vision of the inflection of genome science research."

Genome Canada is a not-for-profit corporation dedicated to developing and implementing a national strategy in genomic and proteomics research for the benefit of all Canadians. Through investments of $840 million to date from the Government of Canada, Genome Canada has become the primary funding and information resource relating to genomics and proteomics in Canada and has established six Genome Centres across the country, in British Columbia, Alberta, the Prairies, Ontario, Quebec, and Atlantic Canada which have become a critical part of the Canadian research landscape.

Contact Information

  • Genome Canada
    Helene Meilleur
    Director of Communications and Events
    613-751-4460, ext. 116 (office)
    613-355-5968 (cell)